On the afternoon of April 14, Caiji Yu, Vice President of Yantai Red Cross Society, and his delegation visited Rongchang Biomedical Park and presented the "Chinese Red Cross Dedication Medal" to Yantai Rongchang Pharmaceuticals in recognition of the company's efforts in the epidemic prevention and control of the novel coronavirus pneumonia.

The "Chinese Red Cross Dedication Medal" is an honor set up by the Red Cross Society of China to recognize the donors who have made significant contributions to the Red Cross humanitarian and public welfare at home and abroad. Since the outbreak of the COVID-19 epidemic in 2020, Rongchang Pharmaceuticals has kept its mission in mind, actively undertakes its social responsibilities. Rongchang donated 1 million yuan and a half million yuan to the Yantai Epidemic Disposal Headquarters and the YEDA Epidemic Disposal Command respectively. In addition, the company has also donated more than 50,000 masks and a batch of protective clothing, disinfectant and other anti-epidemic materials to medical workers, and actively continued to support anti-viral drugs across the country. In order to ensure the production and supply of key epidemic prevention and control materials, Rongchang made efficient and thoughtful arrangements to fully ensure the supply of drugs in the market, and Rongchang people have made contributions to winning the battle against the COVID-19 epidemic.

Winning the "China Red Cross Dedication Medal" is an affirmation of Rongchang Pharmaceutical's support for the "Combating the COVID-19 epidemic" and its long-term fulfillment of corporate social responsibility. In the future, the company will continue to devote itself to public welfare and charity, and contribute more Rongchang power to a healthy China.